Baker D - Search Results

1

Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.

Croxford JL, Pryce G, Jackson SJ, Ledent C, Giovannoni G, Pertwee RG, Yamamura T, Baker D. Croxford JL, et al. Among authors: baker d. J Neuroimmunol. 2008 Jan;193(1-2):120-9. doi: 10.1016/j.jneuroim.2007.10.024. Epub 2007 Nov 26. J Neuroimmunol. 2008. PMID: 18037503

2

Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.

O'Neill JK, Baker D, Turk JL. O'Neill JK, et al. Among authors: baker d. J Neuroimmunol. 1992 Dec;41(2):177-87. doi: 10.1016/0165-5728(92)90068-v. J Neuroimmunol. 1992. PMID: 1469077

3

Therapy of chronic relapsing experimental allergic encephalomyelitis and the role of the blood-brain barrier: elucidation by the action of Brequinar sodium.

O'Neill JK, Baker D, Davison AN, Maggon KK, Jaffee BD, Turk JL. O'Neill JK, et al. Among authors: baker d. J Neuroimmunol. 1992 May;38(1-2):53-62. doi: 10.1016/0165-5728(92)90090-8. J Neuroimmunol. 1992. PMID: 1577953

4

Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice.

Baker D, O'Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL. Baker D, et al. J Neuroimmunol. 1990 Aug;28(3):261-70. doi: 10.1016/0165-5728(90)90019-j. J Neuroimmunol. 1990. PMID: 2373763

5

Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies.

O'Neill JK, Baker D, Davison AN, Allen SJ, Butter C, Waldmann H, Turk JL. O'Neill JK, et al. Among authors: baker d. J Neuroimmunol. 1993 Jun;45(1-2):1-14. doi: 10.1016/0165-5728(93)90157-t. J Neuroimmunol. 1993. PMID: 8331154

6

Polygenic control of experimental allergic encephalomyelitis in Biozzi ABH and BALB/c mice.

Croxford JL, O'Neill JK, Baker D. Croxford JL, et al. Among authors: baker d. J Neuroimmunol. 1997 Apr;74(1-2):205-11. doi: 10.1016/s0165-5728(96)00219-6. J Neuroimmunol. 1997. PMID: 9119975

7

Gene therapy for rheumatoid arthritis. Theoretical considerations.

Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos K, Gould D, Dreja H, Moyes SP, Croxford JL, Mageed RA, Podhajcer OL, Baker D. Chernajovsky Y, et al. Among authors: baker d. Drugs Aging. 1998 Jan;12(1):29-41. doi: 10.2165/00002512-199812010-00004. Drugs Aging. 1998. PMID: 9467685 Review.

8

Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis.

Triantaphyllopoulos K, Croxford J, Baker D, Chernajovsky Y. Triantaphyllopoulos K, et al. Among authors: baker d. Gene Ther. 1998 Feb;5(2):253-63. doi: 10.1038/sj.gt.3300570. Gene Ther. 1998. PMID: 9578846

9

Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: demyelination and fast axonal transport changes in disease.

O'Neill JK, Baker D, Morris MM, Gschmeissner SE, Jenkins HG, Butt AM, Kirvell SL, Amor S. O'Neill JK, et al. Among authors: baker d. J Neuroimmunol. 1998 Mar 1;82(2):210-8. doi: 10.1016/s0165-5728(97)00203-8. J Neuroimmunol. 1998. PMID: 9585818

10

Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system.

Croxford JL, Triantaphyllopoulos K, Podhajcer OL, Feldmann M, Baker D, Chernajovsky Y. Croxford JL, et al. Among authors: baker d. J Immunol. 1998 May 15;160(10):5181-7. J Immunol. 1998. PMID: 9590271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,640 results

Search Page